Inogen, Inc. (INGN)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$5.42-0.55%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · INGN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||
| Revenues | 354.3 | 348.7 | 335.7 | 315.7 | 377.2 | 358.0 | 308.5 | 361.9 | 358.1 | 249.4 | 202.8 | 159.0 | 112.5 |
| Total Revenues | 354.3 | 348.7 | 335.7 | 315.7 | 377.2 | 358.0 | 308.5 | 361.9 | 358.1 | 249.4 | 202.8 | 159.0 | 112.5 |
| Cost of Revenues | 167.4 | 163.8 | 148.7 | 158.6 | 197.8 | 161.8 | 156.8 | 176.0 | 164.0 | 110.2 | 85.2 | 61.6 | 38.7 |
| Gross Profit | 157.7 | 154.3 | 154.7 | 126.7 | 153.5 | 176.5 | 138.2 | 171.9 | 178.6 | 121.2 | 97.3 | 76.3 | 55.5 |
| Operating Expenses & Income | |||||||||||||
| R&D Expenses | 21.1 | 19.4 | 21.6 | 20.8 | 21.9 | 16.6 | 14.1 | 9.4 | 7.0 | 5.3 | 5.1 | 4.2 | 3.0 |
| Operating Income | (30.9) | (30.2) | (42.5) | (109.4) | (85.2) | 9.2 | (12.0) | 19.8 | 37.9 | 27.6 | 22.9 | 15.1 | 10.5 |
| Earnings from Continuing Operations | |||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 |
| Interest & Investment Income | 4.0 | 4.4 | 5.2 | 6.6 | 2.8 | 0.1 | 0.9 | 4.7 | 3.3 | 0.8 | 0.2 | 0.1 | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | (3.3) | (0.8) | (0.2) | (0.1) | 0.4 |
| Other Non-Operating Income / Expenses | 5.5 | 6.8 | 6.0 | 7.0 | 2.0 | (0.6) | 6.7 | 4.5 | 2.6 | 2.1 | (0.1) | (0.3) | (0.5) |
| Asset Writedown | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | — |
| EBT, Incl. Unusual Items | (25.3) | (23.4) | (36.5) | (102.3) | (83.3) | 8.7 | (5.3) | 24.3 | 40.5 | 29.7 | 22.7 | 14.7 | 10.1 |
| Income Tax Expense | (0.7) | (0.6) | (0.6) | 0.1 | 0.5 | 15.0 | 0.5 | 3.3 | (11.4) | 8.7 | 2.2 | 3.1 | 3.2 |
| Net Income | |||||||||||||
| Net Income | 20.9 | (22.7) | (35.9) | 102.4 | 83.8 | 6.3 | (5.8) | 21.0 | 51.8 | 21.0 | 20.5 | 11.6 | 6.8 |
| Per Share | |||||||||||||
| Basic EPS | 0.77 | (0.86) | (1.52) | (4.42) | (3.67) | (0.28) | (0.27) | 0.96 | 2.44 | 1.02 | 1.02 | 0.60 | 0.33 |
| Diluted EPS | 0.77 | (0.86) | (1.52) | (4.42) | (3.67) | (0.28) | (0.27) | 0.94 | 2.30 | 0.96 | 0.97 | 0.56 | 0.30 |
| Revenue per Share | 13.10 | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 27.0 | 26.6 | 23.7 | 23.2 | 22.9 | 22.5 | 22.0 | 21.8 | 21.3 | 20.7 | 20.1 | 19.4 | 16.2 |
| Diluted Weighted Avg Shares | 27.0 | 26.6 | 23.7 | 23.2 | 22.9 | 22.5 | 22.0 | 22.2 | 22.5 | 21.9 | 21.1 | 20.7 | 18.0 |
| Supplemental | |||||||||||||
| EBITDA | — | (14.5) | (25.8) | (92.4) | (70.2) | 22.1 | (2.4) | 29.5 | 47.9 | 39.4 | 36.3 | 29.0 | 22.6 |
| EBIT | (30.9) | (30.2) | (42.5) | (109.4) | (85.2) | 9.2 | (12.0) | 19.8 | 37.9 | 27.6 | 22.9 | 15.1 | 10.5 |
| Effective Tax Rate | 2.8% | — | — | -0.1% | -0.6% | 173.1% | -10.4% | 13.7% | -28.2% | 29.2% | 9.7% | 21.3% | 32.1% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.